Online inquiry

IVTScrip™ mRNA-Human ASGR2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26911MR)

This product GTTS-WK26911MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASGR2 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001181.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 433
UniProt ID P07307
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASGR2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26911MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK11272MR IVTScrip™ mRNA-Human ACTR3, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACTR3
GTTS-WK28000MR IVTScrip™ mRNA-Human ARHGAP45, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARHGAP45
GTTS-WK19221MR IVTScrip™ mRNA-Human AHI1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AHI1
GTTS-WK24379MR IVTScrip™ mRNA-Human ARGLU1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARGLU1
GTTS-WK13732MR IVTScrip™ mRNA-Human ADGRB1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADGRB1
GTTS-WK23877MR IVTScrip™ mRNA-Human ARRDC1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARRDC1
GTTS-WK8954MR IVTScrip™ mRNA-Human ADIPOR2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADIPOR2
GTTS-WK18899MR IVTScrip™ mRNA-Human APBB1IP, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA APBB1IP
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →